Acceder

Publicaciones - HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL

Cargando...
Castano-Diez S, Lopez-Guerra M, Zugasti I, Calvo X, Schulz FI, Avendano A, Mora E, Falantes J, Azaceta G, Ibanez M, Chen T, Notario C, Amer N, Palomo L, Pomares H, Vila J, Bernal Del Castillo T, Jimenez-Vicente C, Esteban D, Guijarro F, Alamo J, Cortes-Bullich A, Torrecillas-Mayayo V, Triguero A, Mont-de Torres L, Carcelero E, Cardus A, Germing U, Betz B, Rozman M, Arenillas L, Zamora L, Diez-Campelo M, Xicoy B, Esteve J, Diaz-Beya M. AML typical mutations (CEBPA, FLT3, NPM1) identify a high-risk chronic myelomonocytic leukemia independent of CPSS molecular. Blood Adv. 2025 Jan 14;9(1):39-53. doi: 10.1182/bloodadvances.2024013648. PubMed PMID: 39388660.
AÑO: 2025; IF: 7.1
Cuenca-Guardiola J., de la Morena-Barrio B., Corral J., Fernández-Breis J.T. Advanced analysis of retrotransposon variation in the human genome with nanopore sequencing using RetroInspector. Scientific Reports. December 2025. 15. 10.1038/s41598-025-98847-7
AÑO: 2025; IF: 3.9
Monreal Bernal A, Berenguer Piqueras M, Ortiz Salvador P, Suarez Terron M, Bataller Alfonso A, Delgado Palacio S, Senent Peris ML, Roig Pellicer M, Villalba Valenzuela A, Benet Campos C, Espinosa Arnandi C, Fernandez Poveda E, Salido Fierez E, Rodenas Quinonero I, de Arriba de la Fuente F, Ortiz Andrade J, Marco Ayala J, Lozano ML, Ortuno FJ. Visceral leishmaniasis in heavily pretreated multiple myeloma patients a case series of 17 patients from the Mediterranean Coast of Spain. Ann Med. 2025 Dec;57(1):2514075. doi: 10.1080/07853890.2025.2514075. Epub 2025 Jun 5. PubMed PMID: 40470770; PubMed Central PMCID: PMC12143001.
AÑO: 2025; IF: 4.3
Manubens A, Paiva B, Gutierrez NC, Fernandez M, Calasanz MJ, Rosinol L, Oriol A, Blanchard MJ, Carrillo E, Benavente C, Martinez-Lopez J, Bargay J, Hernandez MT, de la Rubia J, Gonzalez Y, Paricio M, de Arriba F, Ocio EM, Teruel AI, de la Guia AL, Sirvent M, Gironella M, Sampol A, Arguinano JM, Cabrera C, Alegre A, Granell M, Cabanas V, Nunez-Cordoba JM, Mateos MV, Lahuerta JJ, San Miguel JF, Blade J, Rodriguez-Otero P. High-risk features of early relapse in newly-diagnosed multiple myeloma: The impact of cytogenetics and response to initial therapy. Hemasphere. 2025 Apr 24;9(4):e70127. doi: 10.1002/hem3.70127. eCollection 2025 Apr. PubMed PMID: 40276216; PubMed Central PMCID: PMC12020018.
AÑO: 2025; IF: 14.6
Lozano ML, Lambert MP, Al-Samkari H. Avatrombopag in immune thrombocytopenia and beyond: Current evidence and emerging perspectives. Blood Rev. 2025 Dec 28:101361. doi: 10.1016/j.blre.2025.101361. Online ahead of print. PubMed PMID: 41478740.
AÑO: 2025; IF: 5.7
< AnteriorSiguiente >

Instituto de Investigación Sanitaria Acreditado

ISCII

HEMATOLOGÍA Y ONCOLOGÍA MÉDICA CLÍNICO-EXPERIMENTAL